Suppr超能文献

DICER1 和 DROSHA 对人内皮细胞血管生成能力的影响。

Impact of DICER1 and DROSHA on the Angiogenic Capacity of Human Endothelial Cells.

机构信息

Department of Clinical Pharmacy and Pharmacotherapy, Institute of Pharmacy, Martin-Luther-University Halle-Wittenberg, 06120 Halle (Saale), Germany.

Department of Pharmaceutical Chemistry and Bioanalytics, Institute of Pharmacy, Charles Tanford Center, Martin Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany.

出版信息

Int J Mol Sci. 2021 Sep 12;22(18):9855. doi: 10.3390/ijms22189855.

Abstract

RNAi-mediated knockdown of DICER1 and DROSHA, enzymes critically involved in miRNA biogenesis, has been postulated to affect the homeostasis and the angiogenic capacity of human endothelial cells. To re-evaluate this issue, we reduced the expression of DICER1 or DROSHA by RNAi-mediated knockdown and subsequently investigated the effect of these interventions on the angiogenic capacity of human umbilical vein endothelial cells (HUVEC) (proliferation, migration, tube formation, endothelial cell spheroid sprouting) and in a HUVEC xenograft assay in immune incompetent NSG mice . In contrast to previous reports, neither knockdown of DICER1 nor knockdown of DROSHA profoundly affected migration or tube formation of HUVEC or the angiogenic capacity of HUVEC . Furthermore, knockdown of DICER1 and the combined knockdown of DICER1 and DROSHA tended to increase VEGF-induced BrdU incorporation and induced angiogenic sprouting from HUVEC spheroids. Consistent with these observations, global proteomic analyses showed that knockdown of DICER1 or DROSHA only moderately altered HUVEC protein expression profiles but additively reduced, for example, expression of the angiogenesis inhibitor thrombospondin-1. In conclusion, global reduction of miRNA biogenesis by knockdown of DICER1 or DROSHA does not inhibit the angiogenic capacity of HUVEC. Further studies are therefore needed to elucidate the influence of these enzymes in the context of human endothelial cell-related angiogenesis.

摘要

RNAi 介导的 DICER1 和 DROSHA 敲低,这两种酶在 miRNA 生物发生中起着至关重要的作用,据推测会影响人内皮细胞的动态平衡和血管生成能力。为了重新评估这个问题,我们通过 RNAi 介导的敲低降低了 DICER1 或 DROSHA 的表达,然后研究了这些干预措施对人脐静脉内皮细胞(HUVEC)的血管生成能力的影响(增殖、迁移、管形成、内皮细胞球体发芽),以及在免疫缺陷 NSG 小鼠中的 HUVEC 异种移植实验中。与之前的报道相反,DICER1 或 DROSHA 的敲低都没有显著影响 HUVEC 的迁移或管形成,也没有显著影响 HUVEC 的血管生成能力。此外,DICER1 的敲低和 DICER1 和 DROSHA 的联合敲低往往会增加 VEGF 诱导的 BrdU 掺入,并诱导 HUVEC 球体的血管生成发芽。与这些观察结果一致,全局蛋白质组学分析表明,DICER1 或 DROSHA 的敲低仅适度改变了 HUVEC 的蛋白质表达谱,但例如,联合敲低会导致血管生成抑制剂血栓素-1 的表达降低。总之,DICER1 或 DROSHA 的 miRNA 生物发生的全局减少并不会抑制 HUVEC 的血管生成能力。因此,需要进一步的研究来阐明这些酶在人类内皮细胞相关血管生成中的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcb2/8471234/7fd897693521/ijms-22-09855-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验